Bibliographic citations
Sanchez, C., Herz, M., Gonzales, J., Luque, J., Villegas, S. (2022). Plan estratégico 2022-2025 para una alianza entre laboratorio farmacéutico y retail de medicamentos [Universidad del Pacífico]. https://hdl.handle.net/11354/3838
Sanchez, C., Herz, M., Gonzales, J., Luque, J., Villegas, S. Plan estratégico 2022-2025 para una alianza entre laboratorio farmacéutico y retail de medicamentos []. PE: Universidad del Pacífico; 2022. https://hdl.handle.net/11354/3838
@mastersthesis{sunedu/3382516,
title = "Plan estratégico 2022-2025 para una alianza entre laboratorio farmacéutico y retail de medicamentos",
author = "Villegas Bacigalupo, Sebastian Martin",
publisher = "Universidad del Pacífico",
year = "2022"
}
Pillsens is a company dedicated to the production and sales of over-the-counter (OTC) medications, specialized in analgesics and antioxidants. The company sells its products in France, United States and Finland, having production plants in these two last countries. Pillsens is focused on being the first manufacturer and seller in healthy segment in order to expand their sellings. Pillsens finds the opportunity to establish a strategic alliance with the leading company in health solutions in the United States, CVS. CVS Health is an american healthcare company, owner of CVS Pharmacy (Retail Pharmacy Chain), it is the world's largest corporation serving a single country. It has 9,967 stores throughout the United States, where proximity and concern for providing excellent customer service becomes its differential advantage.
This item is licensed under a Creative Commons License